• 2 Posts
  • 9 Comments
Joined 11 months ago
cake
Cake day: October 24th, 2023

help-circle





  • improvemental@alien.topOPBtoStartupsHelp me review my cold email
    link
    fedilink
    English
    arrow-up
    1
    ·
    10 months ago

    Thanks for the feedback, what do you think of this?

    Hello Mr David,

    we’re building an open-source cancer drug and treatment discovery platform, that centralizes data, and human resources and fosters global collaboration by providing bounty incentives for experts, leading to improvements in drug discovery timelines, better data centralization, and a reduction in research redundancy, The global market for it is at $205.52 billion and we have a unique niche positioning with a clear revenue stream, Warm regards,

    I thought you would be interested in hearing our story because of your experience at X. If you have 15 minutes, I would love to show you our product over Zoom or we can also continue this over email.

    Warm regards, Emmanuel



  • improvemental@alien.topOPBtoStartupsHelp me review my cold email
    link
    fedilink
    English
    arrow-up
    1
    ·
    10 months ago

    u/No_Importance_2338 appreciate the feedback, what do you both think of this?

    Hi David,

    We developed a method of finding cancer treatments that shortens the time needed to create new drugs by over 90% compared to the usual speed-to-market. The majority of novel cancer treatments are taking longer to get to patients. The most promising new treatments have not been effectively fast-tracked because regulators have not been able to keep up with the rate of advancement. In this business, a few weeks’ delay can mean the difference between life and death for hundreds of thousands of people.

    Our goal at MedAI is to reduce the average 10–13-year treatment adoption process to 1-2 years by facilitating collaboration between pharmaceutical companies in countries with severe and lengthy treatment adoption processes and those with fewer and accommodating limitations.

    This method benefits around 21 million people each year in a global market worth approximately $180 billion.

    I would like to opportunity to show you how this works over a Zoom call, Please let me know what day and time this week works best for you.

    Best,

    Emmanuel.


  • improvemental@alien.topOPBtoStartupsHelp me review my cold email
    link
    fedilink
    English
    arrow-up
    1
    ·
    10 months ago

    Please let me know what you think of this.

    Hi David

    We have developed a revolutionary strategy for cancer treatment discovery that cuts the normal speed-to-market of cancer drugs by over 90%. Most novel cancer treatments are experiencing delays in reaching patients. The most promising new therapies have not been effectively fast-tracked due to regulators’ inability to keep up with the rate of research, and this is an industry where a week’s delay can mean life or death for hundreds of thousands of people.

    At AccelerateOncology, our objective is to facilitate collaboration between pharmaceutical companies in countries with severe and lengthy treatment adoption processes and those with less and more accommodating constraints, decreasing the process from 10 -13 years to 1-2 years in time of adoption.

    This method benefits around 21 million people each year in a global market worth approximately $180 billion.

    If you are around for 15 minutes, I would love to show this to you had an exit at X, We can also continue this over email.

    Best, Emmanuel


  • improvemental@alien.topOPBtoStartupsHelp me review my cold email
    link
    fedilink
    English
    arrow-up
    1
    ·
    10 months ago

    What do you think of this?

    Hi David,

    We have a novel approach to cancer treatment discovery that reduces cancer drug development timeline by almost 90% speed-to-market. Most innovative cancer drugs are facing delays in reaching patients Due to regulators not being able to keep up with the pace of progress, the most exciting new therapies have not been successfully fast-tracked in an industry where a weeks delay can mean life or death for hundreds of thousands of people.

    Our approach is facilitating global collaboration between pharmaceutical companies in countries with strict and lengthy treatment adoption processes with those with lower and friendlier restrictions, reducing the process from the typical 10 -13 years to 1-2 years in the time of adoption. This has been validated by the WHO approach to the COVID response. Over 21 million people benefit from this process yearly in a global market of about $180 billion.

    We are seeking a $50,000 investment and I would love for the opportunity to walk you through our platform. I would like to opportunity to show you how this works over a Zoom call, Please let me know what day and time this week works best for you.

    Best,

    Emmanuel.